Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myocardial gene therapy.

J J Mercadier1, D Logeart

  • 1Service de phisiologie, exploration fonctionnelle, groupe hospitalier Bichat-Claude Bernard, Paris. jjmercadier@wanadoo.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|May 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.

Respiratory research·2022
Same author

Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance.

Annales de cardiologie et d'angeiologie·2021
Same author

[ST elevation myocardial infarction in young adults: Is there an interest for thrombophilia screening?]

Annales de cardiologie et d'angeiologie·2018
Same author

Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction.

International journal of cardiology·2016
Same author

Unusual pseudotumoral right atrial involvement in Listeria monocytogenes septicemia.

Circulation·2012
Same author

[Heart failure with preserved ejection fraction: a systemic disorder?].

La Revue de medecine interne·2012
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Myocardial gene therapy shows promise for treating heart failure by improving cardiac function and survival in animal models. While challenges remain for widespread clinical use, surgical applications offer near-term therapeutic potential for myocardial diseases.

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Biotechnology

Background:

  • Myocardial gene therapy emerged in the 1990s, combining pathophysiology knowledge with adenovirus technology.
  • Advancements in vector delivery have enabled therapeutic strategies for conditions like ischemic cardiomyopathies.

Purpose of the Study:

  • To evaluate the potential of myocardial gene therapy for treating experimental heart failure.
  • To assess the efficacy of gene therapy in improving cardiac performance and animal survival.

Main Methods:

  • Utilized recombinant adenovirus vectors for gene delivery in rat models of heart failure.
  • Investigated the delivery of angiogenic factors to the myocardium.

Main Results:

Related Experiment Videos

  • Demonstrated that myocardial gene therapy can enhance cardiac performance in rats with experimental heart failure.
  • Showed that gene therapy significantly prolonged the survival duration of treated animals.

    • Conclusions:

    • Myocardial gene therapy holds promise for human heart failure treatment in the near future.
    • Surgical applications and biotherapies offer potential for significant therapeutic advancements in myocardial diseases.